Trials / Conditions / Prostatic Intraepithelial Neoplasia
Prostatic Intraepithelial Neoplasia
6 registered clinical trials studyying Prostatic Intraepithelial Neoplasia.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Unknown | Annexin A3 (ANXA3) as Protein-Based Marker for Non-Invasive Molecular Diagnostics of Prostate Carcinoma NCT00400894 | ProteoSys AG | — |
| Completed | Broccoli, Peas and PIN NCT00535977 | Quadram Institute Bioscience | N/A |
| Completed | Prostate Cancer Prevention Study for Men With High Grade PIN (Prostatic Intraepithelial Neoplasia) NCT00106691 | GTx | Phase 3 |
| Completed | Finasteride and Flutamide in Pre-surgical Trial in Prostate Cancer. NCT06601205 | Ente Ospedaliero Ospedali Galliera | Phase 2 / Phase 3 |
| Completed | A Pilot Study of Lycopene Supplementation in Prostatic Intraepithelial Neoplasia NCT00178113 | University of Pittsburgh | Phase 1 |
| Completed | A Chemoprevention Study of an Investigational Drug in Men With High Grade Prostate Intraepithelial Neoplasia ( NCT00028353 | GTx | Phase 2 |